vs

Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and First Watch Restaurant Group, Inc. (FWRG). Click either name above to swap in a different company.

First Watch Restaurant Group, Inc. is the larger business by last-quarter revenue ($316.4M vs $168.4M, roughly 1.9× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 20.2%). Over the past eight quarters, First Watch Restaurant Group, Inc.'s revenue compounded faster (14.2% CAGR vs 10.6%).

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

Ruby Tuesday Inc. is an American multinational foodservice retailer that owns, operates, and franchises Ruby Tuesday restaurants. The concept was started in 1972 by Samuel E. (Sandy) Beall III.

ESPR vs FWRG — Head-to-Head

Bigger by revenue
FWRG
FWRG
1.9× larger
FWRG
$316.4M
$168.4M
ESPR
Growing faster (revenue YoY)
ESPR
ESPR
+123.6% gap
ESPR
143.7%
20.2%
FWRG
Faster 2-yr revenue CAGR
FWRG
FWRG
Annualised
FWRG
14.2%
10.6%
ESPR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ESPR
ESPR
FWRG
FWRG
Revenue
$168.4M
$316.4M
Net Profit
Gross Margin
Operating Margin
50.6%
2.9%
Net Margin
Revenue YoY
143.7%
20.2%
Net Profit YoY
EPS (diluted)
$0.32
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESPR
ESPR
FWRG
FWRG
Q4 25
$168.4M
$316.4M
Q3 25
$87.3M
$316.0M
Q2 25
$82.4M
$307.9M
Q1 25
$65.0M
$282.2M
Q4 24
$69.1M
$263.3M
Q3 24
$51.6M
$251.6M
Q2 24
$73.8M
$258.6M
Q1 24
$137.7M
$242.4M
Net Profit
ESPR
ESPR
FWRG
FWRG
Q4 25
Q3 25
$-31.3M
$3.0M
Q2 25
$-12.7M
$2.1M
Q1 25
$-40.5M
$-829.0K
Q4 24
Q3 24
$-29.5M
$2.1M
Q2 24
$-61.9M
$8.9M
Q1 24
$61.0M
$7.2M
Operating Margin
ESPR
ESPR
FWRG
FWRG
Q4 25
50.6%
2.9%
Q3 25
-11.4%
3.2%
Q2 25
8.6%
2.4%
Q1 25
-34.0%
0.4%
Q4 24
-6.4%
1.5%
Q3 24
-31.0%
2.5%
Q2 24
3.5%
6.4%
Q1 24
52.5%
5.1%
Net Margin
ESPR
ESPR
FWRG
FWRG
Q4 25
Q3 25
-35.9%
0.9%
Q2 25
-15.4%
0.7%
Q1 25
-62.2%
-0.3%
Q4 24
Q3 24
-57.2%
0.8%
Q2 24
-83.9%
3.4%
Q1 24
44.3%
3.0%
EPS (diluted)
ESPR
ESPR
FWRG
FWRG
Q4 25
$0.32
$0.24
Q3 25
$-0.16
$0.05
Q2 25
$-0.06
$0.03
Q1 25
$-0.21
$-0.01
Q4 24
$-0.14
$0.01
Q3 24
$-0.15
$0.03
Q2 24
$-0.33
$0.14
Q1 24
$0.34
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESPR
ESPR
FWRG
FWRG
Cash + ST InvestmentsLiquidity on hand
$167.9M
$21.2M
Total DebtLower is stronger
$269.1M
Stockholders' EquityBook value
$-302.0M
$626.3M
Total Assets
$465.9M
$1.7B
Debt / EquityLower = less leverage
0.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESPR
ESPR
FWRG
FWRG
Q4 25
$167.9M
$21.2M
Q3 25
$92.4M
$20.7M
Q2 25
$86.1M
$19.2M
Q1 25
$114.6M
$18.6M
Q4 24
$144.8M
$33.3M
Q3 24
$144.7M
$51.1M
Q2 24
$189.3M
$45.1M
Q1 24
$226.6M
$43.2M
Total Debt
ESPR
ESPR
FWRG
FWRG
Q4 25
$269.1M
Q3 25
$251.0M
Q2 25
$250.0M
Q1 25
$191.5M
Q4 24
$189.0M
Q3 24
$189.7M
Q2 24
$192.1M
Q1 24
$122.7M
Stockholders' Equity
ESPR
ESPR
FWRG
FWRG
Q4 25
$-302.0M
$626.3M
Q3 25
$-451.4M
$607.3M
Q2 25
$-433.5M
$601.3M
Q1 25
$-426.2M
$596.3M
Q4 24
$-388.7M
$595.4M
Q3 24
$-370.2M
$589.1M
Q2 24
$-344.2M
$585.8M
Q1 24
$-294.3M
$574.4M
Total Assets
ESPR
ESPR
FWRG
FWRG
Q4 25
$465.9M
$1.7B
Q3 25
$364.0M
$1.7B
Q2 25
$347.1M
$1.7B
Q1 25
$324.0M
$1.5B
Q4 24
$343.8M
$1.5B
Q3 24
$314.1M
$1.5B
Q2 24
$352.3M
$1.4B
Q1 24
$373.1M
$1.3B
Debt / Equity
ESPR
ESPR
FWRG
FWRG
Q4 25
0.43×
Q3 25
0.41×
Q2 25
0.42×
Q1 25
0.32×
Q4 24
0.32×
Q3 24
0.32×
Q2 24
0.33×
Q1 24
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESPR
ESPR
FWRG
FWRG
Operating Cash FlowLast quarter
$45.2M
$18.5M
Free Cash FlowOCF − Capex
$-18.3M
FCF MarginFCF / Revenue
-5.8%
Capex IntensityCapex / Revenue
0.0%
11.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-31.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESPR
ESPR
FWRG
FWRG
Q4 25
$45.2M
$18.5M
Q3 25
$-4.3M
$47.9M
Q2 25
$-31.4M
$39.4M
Q1 25
$-22.6M
$20.1M
Q4 24
$-35.0M
$22.9M
Q3 24
$-35.3M
$35.9M
Q2 24
$-7.2M
$31.9M
Q1 24
$53.8M
$25.0M
Free Cash Flow
ESPR
ESPR
FWRG
FWRG
Q4 25
$-18.3M
Q3 25
$5.5M
Q2 25
$-1.7M
Q1 25
$-16.4M
Q4 24
$-17.7M
Q3 24
$-35.5M
$6.8M
Q2 24
$-7.3M
$2.3M
Q1 24
$53.8M
$-3.6M
FCF Margin
ESPR
ESPR
FWRG
FWRG
Q4 25
-5.8%
Q3 25
1.7%
Q2 25
-0.5%
Q1 25
-5.8%
Q4 24
-6.7%
Q3 24
-68.7%
2.7%
Q2 24
-9.9%
0.9%
Q1 24
39.0%
-1.5%
Capex Intensity
ESPR
ESPR
FWRG
FWRG
Q4 25
0.0%
11.6%
Q3 25
0.0%
13.4%
Q2 25
0.0%
13.4%
Q1 25
0.0%
13.0%
Q4 24
0.0%
15.4%
Q3 24
0.3%
11.6%
Q2 24
0.1%
11.5%
Q1 24
0.1%
11.8%
Cash Conversion
ESPR
ESPR
FWRG
FWRG
Q4 25
Q3 25
16.01×
Q2 25
18.72×
Q1 25
Q4 24
Q3 24
16.98×
Q2 24
3.59×
Q1 24
0.88×
3.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESPR
ESPR

Collaboration Revenue$124.7M74%
Products$43.7M26%

FWRG
FWRG

In Restaurant Dining Sales$254.1M80%
Third Party Delivery Sales$38.6M12%
Take Out Sales$21.3M7%
Royalty And System Fund Contributions$2.3M1%

Related Comparisons